{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:29:21Z","timestamp":1794047361779,"version":"4.8.0"},"reference-count":103,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"9","license":[{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Red cell pyruvate kinase (PK) deficiency is the most common glycolytic defect associated with congenital non-spherocytic hemolytic anemia. The disease, transmitted as an autosomal recessive trait, is caused by mutations in the PKLR gene and is characterized by molecular and clinical heterogeneity; anemia ranges from mild or fully compensated hemolysis to life-threatening forms necessitating neonatal exchange transfusions and\/or subsequent regular transfusion support; complications include gallstones, pulmonary hypertension, extramedullary hematopoiesis and iron overload. Since identification of the first pathogenic variants responsible for PK deficiency in 1991, more than 300 different variants have been reported, and the study of molecular mechanisms and the existence of genotype-phenotype correlations have been investigated in-depth. In recent years, during which progress in genetic analysis, next-generation sequencing technologies and personalized medicine have opened up important landscapes for diagnosis and study of molecular mechanisms of congenital hemolytic anemias, genotyping has become a prerequisite for accessing new treatments and for evaluating disease state and progression. This review examines the extensive molecular heterogeneity of PK deficiency, focusing on the diagnostic impact of genotypes and new acquisitions on pathogenic non-canonical variants. The recent progress and the weakness in understanding the genotype-phenotype correlation, and its practical usefulness in light of new therapeutic opportunities for PK deficiency are also discussed.<\/jats:p>","DOI":"10.3324\/haematol.2019.241141","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T10:04:41Z","timestamp":1595498681000},"page":"2218-2228","source":"Crossref","is-referenced-by-count":48,"title":["Molecular heterogeneity of pyruvate kinase deficiency"],"prefix":"10.3324","volume":"105","author":[{"given":"Paola","family":"Bianchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Fermo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2020,6,5]]},"reference":[{"key":"3513","doi-asserted-by":"crossref","unstructured":"Nathan DG, Oski FA, Miller DR. Lifespan and organ sequestration of the red cells in pyruvate kinase deficiency. N Engl J Med. 1968; 278(2):73-81. Google Scholar","DOI":"10.1056\/NEJM196801112780203"},{"key":"3514","doi-asserted-by":"crossref","unstructured":"Aisaki K, Aizawa S, Fujii H. Glycolytic inhibition by mutation of pyruvate kinase gene increases oxidative stress and causes apoptosis of a pyruvate kinase deficient cell line. Exp Hematol. 2007; 35(8):1190-1200. Google Scholar","DOI":"10.1016\/j.exphem.2007.05.005"},{"key":"3515","doi-asserted-by":"crossref","unstructured":"Andres O, Loewecke F, Morbach H. Hereditary spherocytosis is associated with decreased pyruvate kinase activity due to impaired structural integrity of the red blood cell membrane. Br J Haematol. 2019; 187(3):386-395. Google Scholar","DOI":"10.1111\/bjh.16084"},{"key":"3516","doi-asserted-by":"crossref","unstructured":"Boivin P, Galand C, Hakim J. Acquired red cell pyruvate kinase deficiency in leukemias and related disorders. Enzyme. 1975; 19(5-6):294-299. Google Scholar","DOI":"10.1159\/000459004"},{"key":"3517","unstructured":"Lin G, Xie Y, Liang X, Wu X. Study on red cell enzymes and isoenzymes in patients with leukemia and myelodysplastic syndromes. Zhonghua Xue Ye Xue Za Zhi. 1997; 18(7):350-353. Google Scholar"},{"key":"3518","doi-asserted-by":"crossref","unstructured":"Mattevi A, Valentini G, Rizzi M. Crystal structure of Escherichia coli pyruvate kinase type I: molecular basis of the allosteric transition. Structure. 1995; 3:729-741. Google Scholar","DOI":"10.1016\/S0969-2126(01)00207-6"},{"key":"3519","doi-asserted-by":"crossref","unstructured":"Muirhead H, Clayden DA, Barford D. The structure of cat muscle pyruvate kinase. EMBO J. 1986; 5:475-481. Google Scholar","DOI":"10.1002\/j.1460-2075.1986.tb04236.x"},{"key":"3520","doi-asserted-by":"crossref","unstructured":"Larsen TM, Laughlin LT, Holden HM. Structure of rabbit muscle pyruvate kinase complexed with Mn2+, K+, and pyruvate. Biochemistry. 1994; 33(20):6301-6309. Google Scholar","DOI":"10.1021\/bi00186a033"},{"key":"3521","doi-asserted-by":"crossref","unstructured":"Valentini G, Chiarelli LR, Fortin R, Speranza ML, Galizzi A, Mattevi A.. The allosteric regulation of pyruvate kinase. J Biol Chem. 2000; 275(24):18145-18152. Google Scholar","DOI":"10.1074\/jbc.M001870200"},{"key":"3522","doi-asserted-by":"crossref","unstructured":"Valentini G, Chiarelli LR, Fortin R. Structure and function of human erythrocyte pyruvate kinase. Molecular basis of nonspherocytic hemolytic anemia. J Biol Chem. 2002; 277(26):23807-23814. Google Scholar","DOI":"10.1074\/jbc.M202107200"},{"key":"3523","doi-asserted-by":"crossref","unstructured":"Kung C, Hixon J, Kosinski PA. AG-348 enhances pyruvate kinase activity in red blood cells from patients with pyruvate kinase deficiency. Blood. 2017; 130(11):1347-1356. Google Scholar","DOI":"10.1182\/blood-2016-11-753525"},{"key":"3524","doi-asserted-by":"crossref","unstructured":"Jurica MS, Mesecar A, Heath PJ. The allosteric regulation of pyruvate kinase by fructose-1,6-bisphosphate. Structure. 1998; 6:195-210. Google Scholar","DOI":"10.1016\/S0969-2126(98)00021-5"},{"key":"3525","doi-asserted-by":"crossref","unstructured":"Wang C, Chiarelli LR, Bianchi P. Human erythrocyte pyruvate kinase: characterization of the recombinant enzyme and a mutant form (R510Q) causing nonspherocytic hemolytic anemia. Blood. 2001; 98(10):3113-3120. Google Scholar","DOI":"10.1182\/blood.V98.10.3113"},{"key":"3526","doi-asserted-by":"crossref","unstructured":"Kedar P, Hamada T, Warang P. Spectrum of novel mutations in the human PKLR gene in pyruvate kinase-deficient Indian patients with heterogeneous clinical phenotypes. Clin Genet. 2009; 75(2):157-162. Google Scholar","DOI":"10.1111\/j.1399-0004.2008.01079.x"},{"key":"3527","doi-asserted-by":"crossref","unstructured":"Svidnicki MCCM, Santos A, Fernandez JAA. Novel mutations associated with pyruvate kinase deficiency in Brazil. Rev Bras Hematol Hemoter. 2018; 40(1):5-11. Google Scholar","DOI":"10.1016\/j.bjhh.2017.08.007"},{"key":"3528","doi-asserted-by":"crossref","unstructured":"Zanella A, Fermo E, Bianchi P. Pyruvate kinase deficiency: the genotype-phenotype association. Blood Rev. 2007; 21(4):217-231. Google Scholar","DOI":"10.1016\/j.blre.2007.01.001"},{"key":"3529","doi-asserted-by":"crossref","unstructured":"Fermo E, Bianchi P, Chiarelli LR. Red cell pyruvate kinase deficiency: 17 new mutations of the PK-LR gene. Br J Haematol. 2005; 129(6):839-846. Google Scholar","DOI":"10.1111\/j.1365-2141.2005.05520.x"},{"key":"3530","unstructured":"Beutler E. Red Cell Metabolism: A Manual of Biochemical Methods. 1984. Google Scholar"},{"key":"3531","doi-asserted-by":"crossref","unstructured":"Bianchi P, Fermo E, Glader B. with the endorsement of EuroBloodNet the European Reference Network in Rare Hematological Diseases. Addressing the diagnostic gaps in pyruvate kinase deficiency: consensus recommendations on the diagnosis of pyruvate kinase deficiency. Am J Hematol. 2019; 94(1):149-161. Google Scholar","DOI":"10.1002\/ajh.25325"},{"key":"3532","doi-asserted-by":"crossref","unstructured":"Agarwal AM, Nussenzveig RH, Reading NS. Clinical utility of next-generation sequencing in the diagnosis of hereditary haemolytic anaemias. Br J Haematol. 2016; 174(5):806-814. Google Scholar","DOI":"10.1111\/bjh.14131"},{"key":"3533","doi-asserted-by":"crossref","unstructured":"Del Orbe Barreto R, Arrizabalaga B, De la Hoz AB. Detection of new pathogenic mutations in patients with congenital haemolytic anaemia using next-generation sequencing. Int J Lab Hematol. 2016; 38(6):629-638. Google Scholar","DOI":"10.1111\/ijlh.12551"},{"key":"3534","unstructured":"Iwasaki T, Yamamoto T, Muramatsu H. Clinical impact of captured-based targeted sequencing in diagnosis of congenital hemolytic anaemia. Rinsho Ketsueki. 2016; 57:1489. Google Scholar"},{"key":"3535","doi-asserted-by":"crossref","unstructured":"Roy NB, Wilson EA, Henderson S.. A novel 33-gene targeted resequencing panel provides accurate, clinical-grade diagnosis and improves patient management for rare inherited anaemias. Br J Haematol. 2016; 175(2):318-330. Google Scholar","DOI":"10.1111\/bjh.14221"},{"key":"3536","unstructured":"Fermo E, Vercellati C, Marcello AP. Use of next generation sequencing panel to clari - fy undiagnosed cases of hereditary hemolytic anaemias. Blood. 2017; 130(Supplement 1):3480. Google Scholar"},{"key":"3537","doi-asserted-by":"crossref","unstructured":"Russo R, Andolfo I, Manna F, Gambale A. Multi-gene panel testing improves diagnosis and management of patients with hereditary anemias. Am J Hematol. 2018; 93(5):672-682. Google Scholar","DOI":"10.1002\/ajh.25058"},{"key":"3538","doi-asserted-by":"crossref","unstructured":"Al-Samkari H, van Beers EJ, Kuo KHM. The variable manifestations of disease in pyruvate kinase deficiency and their management. Haematologica. 2020; 105(9):2229-2239. Google Scholar","DOI":"10.3324\/haematol.2019.240846"},{"key":"3539","doi-asserted-by":"crossref","unstructured":"Shefer Averbuch N, Steinberg-Shemer O, Dgany O. Targeted next generation sequencing for the diagnosis of patients with rare congenital anemias. Eur J Haematol. 2018; 101(3):297-304. Google Scholar","DOI":"10.1111\/ejh.13097"},{"key":"3540","doi-asserted-by":"crossref","unstructured":"Jamwal M, Aggarwal A, Palodhi A. Next-generation sequencing-based diagnosis of unexplained inherited hemolytic anemias reveals wide genetic and phenotypic heterogeneity. J Mol Diagn. 2020; 22(4):579-590. Google Scholar","DOI":"10.1016\/j.jmoldx.2020.01.007"},{"key":"3541","doi-asserted-by":"crossref","unstructured":"Qin L, Nie Y, Chen L. Novel PLKR mutations in four families with pyruvate kinase deficiency. Int J Lab Hematol. 2020; 42(2):e84-e87. Google Scholar","DOI":"10.1111\/ijlh.13123"},{"key":"3542","doi-asserted-by":"crossref","unstructured":"Kedar PS, Harigae H, Ito E. Study of pathophysiology and molecular characterization of congenital anemia in India using targeted next-generation sequencing approach. Int J Hematol. 2019; 110(5):618-626. Google Scholar","DOI":"10.1007\/s12185-019-02716-9"},{"key":"3543","doi-asserted-by":"crossref","unstructured":"Kanno H, Fujii H, Miwa S.. Structural analysis of human pyruvate kinase L-gene and identification of the promoter activity in erythroid cells. Biochem Biophys Res Commun. 1992; 188(2):516-523. Google Scholar","DOI":"10.1016\/0006-291X(92)91086-6"},{"key":"3544","doi-asserted-by":"crossref","unstructured":"Noguchi T, Tamada K, Inoue H. The Land R-type isozymes of rat pyruvate kinase are produced from a single gene by use of different promoters. J Biol Chem. 1987; 262(29):14366-14371. Google Scholar","DOI":"10.1016\/S0021-9258(18)47947-1"},{"key":"3545","doi-asserted-by":"crossref","unstructured":"Canu G, De Bonis M, Minucci A, Capoluongo E.. Red blood cell PK deficiency: an update of PK-LR gene mutation database. Blood Cells Mol Dis. 2016; 57:100-109. Google Scholar","DOI":"10.1016\/j.bcmd.2015.12.009"},{"key":"3546","doi-asserted-by":"crossref","unstructured":"Grace RF, Bianchi P, van Beers EJ. Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study. Blood. 2018; 131(20):2183-2192. Google Scholar","DOI":"10.1182\/blood-2017-10-810796"},{"key":"3547","doi-asserted-by":"crossref","unstructured":"Bianchi P, Fermo E, Lezon-Geyda K. Genotype-phenotype correlation and molecular heterogeneity in pyruvate kinase deficiency. Am J Hematol. 2020; 95(5):472-482. Google Scholar","DOI":"10.1002\/ajh.25753"},{"key":"3548","doi-asserted-by":"crossref","unstructured":"Warang P, Kedar P, Ghosh K. Molecular and clinical heterogeneity in pyruvate kinase deficiency in India. Blood Cells Mol Dis. 2013; 51(3):133-137. Google Scholar","DOI":"10.1016\/j.bcmd.2013.05.006"},{"key":"3549","doi-asserted-by":"crossref","unstructured":"Zanella A, Bianchi P.. Red cell pyruvate kinase deficiency: from genetics to clinical manifestations. Baillieres Best Pract Res Clin Haematol. 2000; 13(1):57-81. Google Scholar","DOI":"10.1053\/beha.1999.0057"},{"key":"3550","doi-asserted-by":"crossref","unstructured":"Kanno H, Ballas SK, Miwa S. Molecular abnormality of erythrocyte pyruvate kinase deficiency in the Amish. Blood. 1994; 83(8):2311-2316. Google Scholar","DOI":"10.1182\/blood.V83.8.2311.bloodjournal8382311"},{"key":"3551","doi-asserted-by":"crossref","unstructured":"Machado P, Manco L, Gomes C. Pyruvate kinase deficiency in sub-Saharan Africa: identification of a highly frequent missense mutation (G829A;Glu277Lys) and association with malaria. PLoS One. 2012; 7:e47071. Google Scholar","DOI":"10.1371\/journal.pone.0047071"},{"key":"3552","doi-asserted-by":"crossref","unstructured":"Baronciani L, Beutler E.. Molecular study of pyruvate kinase deficient patients with hereditary nonspherocytic hemolytic anemia. J Clin Invest. 1995; 95(4):1702-1709. Google Scholar","DOI":"10.1172\/JCI117846"},{"key":"3553","unstructured":"Costa C, Albuisson J, Le TH. Severe hemolytic anemia in a Vietnamese family, associated with novel mutations in the gene encoding for pyruvate kinase. Haematologica. 2005; 90(1):25-30. Google Scholar"},{"key":"3554","doi-asserted-by":"crossref","unstructured":"Richards S, Aziz N, Bale S. ACMG Laboratory Quality Assurance Committee.Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5):405-424. Google Scholar","DOI":"10.1038\/gim.2015.30"},{"key":"3555","doi-asserted-by":"crossref","unstructured":"Marcello AP, Vercellati C, Fermo E. A case of congenital red cell pyruvate kinase deficiency associated with hereditary stomatocytosis. Blood Cells Mol Dis. 2008; 41(3):261-262. Google Scholar","DOI":"10.1016\/j.bcmd.2008.07.001"},{"key":"3556","doi-asserted-by":"crossref","unstructured":"Coutinho R, Bento C, Almeida H. Complex inheritance of chronic haemolytic anaemia. Br J Haematol. 2009; 144(4):615-616. Google Scholar","DOI":"10.1111\/j.1365-2141.2008.07479.x"},{"key":"3557","doi-asserted-by":"crossref","unstructured":"Manco L, Ribeiro ML, Maximo V. A new PKLR gene mutation in the R\u2010type promoter region affects the gene transcription causing pyruvate kinase deficiency. Br J Haematol. 2000; 110(4):993-997. Google Scholar","DOI":"10.1046\/j.1365-2141.2000.02283.x"},{"key":"3558","doi-asserted-by":"crossref","unstructured":"van Wijk R, van Solinge WW, Nerlov C. Disruption of a novel regulatory element in the erythroid\u2010specific promoter of the human PKLR gene causes severe pyruvate kinase deficiency. Blood. 2003; 101(4):1596-1602. Google Scholar","DOI":"10.1182\/blood-2002-07-2321"},{"key":"3559","doi-asserted-by":"crossref","unstructured":"Kager L, Minkov M, Zeitlhofer P. Two novel missense mutations and a 5bp deletion in the erythroid-specific promoter of the PKLR gene in two unrelated patients with pyruvate kinase deficient transfusiondependent chronic nonspherocytic hemolytic anemia. Pediatr Blood Cancer. 2016; 63(5):914-916. Google Scholar","DOI":"10.1002\/pbc.25878"},{"key":"3560","doi-asserted-by":"crossref","unstructured":"Pissard S, Max-Audit I, Skopinski L. Pyruvate kinase deficiency in France: a 3- year study reveals 27 new mutations. Br J Haematol. 2006; 133(6):683-689. Google Scholar","DOI":"10.1111\/j.1365-2141.2006.06076.x"},{"key":"3561","doi-asserted-by":"crossref","unstructured":"de Vooght KM, van Wijk R, van Wesel AC. Characterization of the -148C&gt;T promoter polymorphism in PKLR. Haematologica. 2008; 93(9):1407-1408. Google Scholar","DOI":"10.3324\/haematol.12328"},{"key":"3562","doi-asserted-by":"crossref","unstructured":"Gallagher PG, Glader B.. Diagnosis of pyruvate kinase deficiency. Pediatr Blood Cancer. 2016; 63(5):771-772. Google Scholar","DOI":"10.1002\/pbc.25922"},{"key":"3563","doi-asserted-by":"crossref","unstructured":"Titapiwatanakun R, Hoyer JD, Crain K. Relative red blood cell enzyme levels as a clue to the diagnosis of pyruvate kinase deficiency. Pediatr Blood Cancer. 2008; 51(6):819-821. Google Scholar","DOI":"10.1002\/pbc.21720"},{"key":"3564","doi-asserted-by":"crossref","unstructured":"Zanella A, Bianchi P, Baronciani L. Molecular characterization of PK-LR gene in pyruvate kinase-deficient Italian patients. Blood. 1997; 89(10):3847-3852. Google Scholar","DOI":"10.1182\/blood.V89.10.3847.3847_3847_3852"},{"key":"3565","doi-asserted-by":"crossref","unstructured":"Gallagher PG, Maksimova Y, Lezon-Geyda K. Aberrant splicing contributes to severe -spectrin-linked congenital hemolytic anemia. J Clin Invest. 2019; 129(7):2878-2887. Google Scholar","DOI":"10.1172\/JCI127195"},{"key":"3566","doi-asserted-by":"crossref","unstructured":"Grace RF, Rose C, Layton M. Safety and efficacy of mitapivat in pyruvate kinase deficiency. N Engl J Med. 2019; 381(10):933-944. Google Scholar","DOI":"10.1056\/NEJMoa1902678"},{"key":"3567","doi-asserted-by":"crossref","unstructured":"Lezon-Geyda K, Rose MJ, McNaull MA. PKLR intron splicing-associated mutations and alternate diagnoses are common in pyruvate kinase deficient patients with single or no PKLR coding mutations. Blood. 2018; 132(Suppl 1):3607. Google Scholar","DOI":"10.1182\/blood-2018-99-117805"},{"key":"3568","doi-asserted-by":"crossref","unstructured":"Bagla S, Bhambhani K, Gadgeel M. Compound heterozygosity in PKLR gene for a previously unrecognized intronic polymorphism and a rare missense mutation as a novel cause of severe pyruvate kinase deficiency. Haematologica. 2019; 104(9):e428-e431. Google Scholar","DOI":"10.3324\/haematol.2018.214692"},{"key":"3569","doi-asserted-by":"crossref","unstructured":"Lesmana H, Dyer L, Li X. Alu element insertion in PKLR gene as a novel cause of pyruvate kinase deficiency in Middle Eastern patients. Hum Mutat. 2018; 39(3):389-393. Google Scholar","DOI":"10.1002\/humu.23392"},{"key":"3570","unstructured":"Zurcher C, Loos JA, Prins HK. Hereditary high ATP content of human erythrocytes. Folia Haematol Int Mag Klin Morphol Blutforsch. 1965; 83(4):366-376. Google Scholar"},{"key":"3571","doi-asserted-by":"crossref","unstructured":"Max-Audit I, Rosa R, Marie J.. Pyruvate kinase hyperactivity genetically determined: metabolic consequences and molecular characterization. Blood. 1980; 56(5):902-909. Google Scholar","DOI":"10.1182\/blood.V56.5.902.bloodjournal565902"},{"key":"3572","doi-asserted-by":"crossref","unstructured":"van Oirschot BA, Francois JJ, van Solinge WW. Novel type of red blood cell pyruvate kinase hyperactivity predicts a remote regulatory locus involved in PKLR gene expression. Am J Hematol. 2014; 89(4):380-384. Google Scholar","DOI":"10.1002\/ajh.23647"},{"key":"3573","doi-asserted-by":"crossref","unstructured":"Beutler E, Westwood B, van Zwieten R. G\u2010&gt;T transition at cDNA nt 110 (K37Q) in the PKLR (pyruvate kinase) gene is the molecular basis of a case of hereditary increase of red blood cell ATP. Hum Mutat. 1997; 9(3):282-285. Google Scholar","DOI":"10.1002\/(SICI)1098-1004(1997)9:3<282::AID-HUMU13>3.0.CO;2-Z"},{"key":"3574","doi-asserted-by":"crossref","unstructured":"Viprakasit V, Ekwattanakit S, Riolueang S. Mutations in Kruppel-like factor 1 cause transfusion-dependent hemolytic anemia and persistence of embryonic globin gene expression. Blood. 2014; 123(10):1586-1595. Google Scholar","DOI":"10.1182\/blood-2013-09-526087"},{"key":"3575","doi-asserted-by":"crossref","unstructured":"Beutler E, Gelbart T.. Estimating the prevalence of pyruvate kinase deficiency from the gene frequency in the general white population. Blood. 2000; 95(11):3585-3588. Google Scholar","DOI":"10.1182\/blood.V95.11.3585.011k39_3585_3588"},{"key":"3576","doi-asserted-by":"crossref","unstructured":"Carey PJ, Chandler J, Hendrick A. Prevalence of pyruvate kinase deficiency in northern European population in the north of England. Northern Region Haematologists Group. Blood. 2000; 96(12):4005-4006. Google Scholar","DOI":"10.1182\/blood.V96.12.4005"},{"key":"3577","doi-asserted-by":"crossref","unstructured":"Secrest MH, Storm M, Carrington C. Prevalence of pyruvate kinase deficiency: a systematic literature review. Eur J Haematol. 2020. Google Scholar","DOI":"10.1111\/ejh.13424"},{"key":"3578","doi-asserted-by":"crossref","unstructured":"van Bruggen R, Gualtieri C, Iliescu A. Modulation of malaria phenotypes by pyruvate kinase (PKLR) variants in a Thai population. PLoS One. 2015; 10:e0144555. Google Scholar","DOI":"10.1371\/journal.pone.0144555"},{"key":"3579","doi-asserted-by":"crossref","unstructured":"Min-Oo G, Fortin A, Tam MF. Pyruvate kinase deficiency in mice protects against malaria. Nat Genet. 2003; 35(4):357-362. Google Scholar","DOI":"10.1038\/ng1260"},{"key":"3580","doi-asserted-by":"crossref","unstructured":"Ayi K, Min-Oo G, Serghides L. Pyruvate kinase deficiency and malaria. New Eng J Med. 2008; 358(17):1805-1810. Google Scholar","DOI":"10.1056\/NEJMoa072464"},{"key":"3581","doi-asserted-by":"crossref","unstructured":"Qidwai T, Jamal F, Singh S.. Exploring putative molecular mechanisms of human pyruvate kinase enzyme deficiency and its role in resistance against Plasmodium falciparum malaria. Interdiscipl Sci. 2014; 6(2):158-166. Google Scholar","DOI":"10.1007\/s12539-013-0025-8"},{"key":"3582","doi-asserted-by":"crossref","unstructured":"van Wijk R, Huizinga EG, van Wesel AC. Fifteen novel mutations in PKLR associated with pyruvate kinase (PK) deficiency: structural implications of amino acid substitutions in PK. Hum Mutat. 2009; 30(3):446-453. Google Scholar","DOI":"10.1002\/humu.20915"},{"key":"3583","doi-asserted-by":"crossref","unstructured":"Jaouani M, Manco L, Kalai M. Molecular basis of pyruvate kinase deficiency among Tunisians: description of new mutations affecting coding and noncoding regions in the PKLR gene. Int J Lab Hematol. 2017; 39(2):223-231. Google Scholar","DOI":"10.1111\/ijlh.12610"},{"key":"3584","doi-asserted-by":"crossref","unstructured":"Christensen RD, Yaish HM, Johnson CB. Six children with pyruvate kinase deficiency from one small town: molecular characterization of the PK-LR gene. J Pediatr. 2011; 159(4):695-697. Google Scholar","DOI":"10.1016\/j.jpeds.2011.05.043"},{"key":"3585","doi-asserted-by":"crossref","unstructured":"Lakomek M, Winkler H, Pekrun A. Erythrocyte pyruvate kinase deficiency. The influence of physiologically important metabolites on the function of normal and defective enzymes. Enzyme Protein. 1994; 48(3):149-163. Google Scholar","DOI":"10.1159\/000474982"},{"key":"3586","doi-asserted-by":"crossref","unstructured":"Finkenstedt A, Bianchi P, Theurl I. Regulation of iron metabolism through GDF15 and hepcidin in pyruvate kinase deficiency. Br J Haematol. 2009; 144(5):789-793. Google Scholar","DOI":"10.1111\/j.1365-2141.2008.07535.x"},{"key":"3587","doi-asserted-by":"crossref","unstructured":"Goto T, Ubukawa K, Kobayashi I. ATP produced by anaerobic glycolysis is essential for enucleation of human erythroblasts. Exp Hematol. 2019; 72:14-26. Google Scholar","DOI":"10.1016\/j.exphem.2019.02.004"},{"key":"3588","doi-asserted-by":"crossref","unstructured":"van Beers EJ, van Straaten S, Morton DH. Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study. Haematologica. 2019; 104(2):e51-e53. Google Scholar","DOI":"10.3324\/haematol.2018.196295"},{"key":"3589","doi-asserted-by":"crossref","unstructured":"Zanella A, Berzuini A, Colombo MB. Iron status in red cell pyruvate kinase deficiency: study of Italian cases. Br J Haematol. 1993; 83(3):485-490. Google Scholar","DOI":"10.1111\/j.1365-2141.1993.tb04675.x"},{"key":"3590","doi-asserted-by":"crossref","unstructured":"Mojzikova R, Koralkova P, Holub D. Iron status in patients with pyruvate kinase deficiency: neonatal hyperferritinaemia associated with a novel frameshift deletion in the PKLR gene (p.Arg518fs), and low hepcidin to ferritin ratios. Br J Haematol. 2014; 165(4):556-563. Google Scholar","DOI":"10.1111\/bjh.12779"},{"key":"3591","doi-asserted-by":"crossref","unstructured":"Zanella A, Bianchi P, Iurlo A. Iron status and HFE genotype in erythrocyte pyruvate kinase deficiency: study of Italian cases. Blood Cells Mol Dis. 2001; 27(3):653-661. Google Scholar","DOI":"10.1006\/bcmd.2001.0433"},{"key":"3592","doi-asserted-by":"crossref","unstructured":"Rider NL, Strauss KA, Brown K. Erythrocyte pyruvate kinase deficiency in an old-order Amish cohort: longitudinal risk and disease management. Am J Hematol. 2011; 86(10):827-834. Google Scholar","DOI":"10.1002\/ajh.22118"},{"key":"3593","doi-asserted-by":"crossref","unstructured":"Grace RF, Zanella A, Neufeld EJ. Erythrocyte pyruvate kinase deficiency: 2015 status report. Am J Hematol. 2015; 90(9):825-830. Google Scholar","DOI":"10.1002\/ajh.24088"},{"key":"3594","doi-asserted-by":"crossref","unstructured":"Perseu L, Giagu N, Satta S. Red cell pyruvate kinase deficiency in Southern Sardinia. Blood Cells Mol Dis. 2010; 45(4):280-283. Google Scholar","DOI":"10.1016\/j.bcmd.2010.08.006"},{"key":"3595","doi-asserted-by":"crossref","unstructured":"Branca R, Costa E, Rocha S. Coexistence of congenital red cell pyruvate kinase and band 3 deficiency. Clin Lab Haematol. 2004; 26(4):297-300. Google Scholar","DOI":"10.1111\/j.1365-2257.2004.00617.x"},{"key":"3596","doi-asserted-by":"crossref","unstructured":"Christensen RD, Yaish HM, Nussenzveig RH, Agarwal AM. Siblings with severe pyruvate kinase deficiency and a complex genotype. Am J Med Genet A. 2016; 170(9):2449-2452. Google Scholar","DOI":"10.1002\/ajmg.a.37828"},{"key":"3597","doi-asserted-by":"crossref","unstructured":"Vercellati C, Marcello AP, Fermo E. A case of hereditary spherocytosis misdiagnosed as pyruvate kinase deficient hemolytic anemia. Clin Lab. 2013; 59(3-4):421-424. Google Scholar","DOI":"10.7754\/Clin.Lab.2012.120905"},{"key":"3598","doi-asserted-by":"crossref","unstructured":"Fermo E, Vercellati C, Marcello AP. Hereditary xerocytosis due to mutations in piezo1 gene associated with heterozygous pyruvate kinase deficiency and beta-thalassemia trait in two unrelated families. Case Rep Hematol. 2017; 2017:2769570. Google Scholar","DOI":"10.1155\/2017\/2769570"},{"key":"3599","doi-asserted-by":"crossref","unstructured":"Cohen-Solal M, Pr\u00e9hu C, Wajcman H. A new sickle cell disease phenotype associating Hb S trait, severe pyruvate kinase deficiency (PK Conakry), and an alpha2 globin gene variant (Hb Conakry). Br J Haematol. 1998; 103(4):950-956. Google Scholar","DOI":"10.1046\/j.1365-2141.1998.01094.x"},{"key":"3600","doi-asserted-by":"crossref","unstructured":"Alli N, Coetzee M, Louw V. Sickle cell disease in a carrier with pyruvate kinase deficiency. Hematology. 2008; 13(6):369-372. Google Scholar","DOI":"10.1179\/102453308X343536"},{"key":"3601","doi-asserted-by":"crossref","unstructured":"Manco L, Vagace JM, Relvas L. Chronic haemolytic anaemia because of pyruvate kinase (PK) deficiency in a child heterozygous for haemoglobin S and no clinical features of sickle cell disease. Eur J Haematol. 2010; 84(1):89-90. Google Scholar","DOI":"10.1111\/j.1600-0609.2009.01353.x"},{"key":"3602","unstructured":"Zarza R, Moscardo M, Alvarez R. Coexistence of hereditary spherocytosis and a new red cell pyruvate kinase variant: PK Mallorca. Haematologica. 2000; 85(3):227-232. Google Scholar"},{"key":"3603","doi-asserted-by":"crossref","unstructured":"van Zwieten R, van Oirschot BA, Veldthuis M. Partial pyruvate kinase deficiency aggravates the phenotypic expression of band 3 deficiency in a family with hereditary spherocytosis. Am J Hematol. 2015; 90(3):E35-E39. Google Scholar","DOI":"10.1002\/ajh.23899"},{"key":"3604","doi-asserted-by":"crossref","unstructured":"Pereira J, Gonzalez A, Vagace J. Congenital dyserythropoietic anemia associated to a GATA1 mutation aggravated by pyruvate kinase deficiency. Ann Hematol. 2016; 95(9):1551-1553. Google Scholar","DOI":"10.1007\/s00277-016-2720-0"},{"key":"3605","doi-asserted-by":"crossref","unstructured":"van Straaten S, Bierings M, Bianchi P. Worldwide study of hematopoietic allogeneic stem cell transplantation in pyruvate kinase deficiency. Haematologica. 2018; 103(2):e82-e86. Google Scholar","DOI":"10.3324\/haematol.2017.177857"},{"key":"3606","doi-asserted-by":"crossref","unstructured":"He Y, Luo J, Lei Y. A novel PKLR gene mutation identified using advanced molecular techniques. Pediatr Transplant. 2018; 22(2):e13143. Google Scholar","DOI":"10.1111\/petr.13143"},{"key":"3607","doi-asserted-by":"crossref","unstructured":"Shimomura M, Doi T, Nishimura S. Successful allogeneic bone marrow transplantation using immunosuppressive conditioning regimen for a patient with red blood cell transfusion dependent pyruvate kinase deficiency anemia. Hematol Rep. 2020; 12(1):8305. Google Scholar","DOI":"10.4081\/hr.2020.8305"},{"key":"3608","doi-asserted-by":"crossref","unstructured":"Yang H, Merica E, Chen Y. Phase 1 single and multiple-ascending-dose randomized studies of the safety, pharmacokinetics, and pharmacodynamics of AG-348, a firstin- class allosteric activator of pyruvate kinase R, in healthy volunteers. Clin Pharmacol Drug Dev. 2019; 8(2):246-259. Google Scholar","DOI":"10.1002\/cpdd.604"},{"key":"3609","doi-asserted-by":"crossref","unstructured":"Rab MAE, van Oirschot BA, Kosinski PA. AG-348 (Mitapivat), an allosteric activator of red blood cell pyruvate kinase, increases enzymatic activity, protein stability, and ATP levels over a broad range of PKLR genotypes. Haematologica. 2020. Google Scholar","DOI":"10.3324\/haematol.2019.238865"},{"key":"3610","doi-asserted-by":"crossref","unstructured":"Dunbar CE, High KA, Joung JK. Gene therapy comes of age. Science. 2018; 359(6372):eaan4672. Google Scholar","DOI":"10.1126\/science.aan4672"},{"key":"3611","doi-asserted-by":"crossref","unstructured":"Magrin E, Miccio A, Cavazzana M.. Lentiviral and genome-editing strategies for the treatment of -hemoglobinopathies. Blood. 2019; 134(15):1203-1213. Google Scholar","DOI":"10.1182\/blood.2019000949"},{"key":"3612","doi-asserted-by":"crossref","unstructured":"Meza NW, Alonso-Ferrero ME, Navarro S. Rescue of pyruvate kinase deficiency in mice by gene therapy using the human isoenzyme. Mol Ther. 2009; 17(12):2000-2009. Google Scholar","DOI":"10.1038\/mt.2009.200"},{"key":"3613","doi-asserted-by":"crossref","unstructured":"Meza NW, Quintana-Bustamante O, Puyet A. In vitro and in vivo expression of human erythrocyte pyruvate kinase in erythroid cells: a gene therapy approach. Hum Gene Ther. 2007; 18(6):502-514. Google Scholar","DOI":"10.1089\/hum.2006.052"},{"key":"3614","doi-asserted-by":"crossref","unstructured":"Garcia-Gomez M, Calabria A, Garcia-Bravo M. Safe and efficient gene therapy for pyruvate kinase deficiency. Mol Ther. 2016; 24(7):1187-1198. Google Scholar","DOI":"10.1038\/mt.2016.87"},{"key":"3615","doi-asserted-by":"crossref","unstructured":"Quintana-Bustamante O, Fa\u00f1anas-Baquero S, Orman I. Gene editing of PKLR gene in human hematopoietic progenitors through 5' and 3' UTR modified TALEN mRNA. PLoS One. 2019; 14(10):e0223775. Google Scholar","DOI":"10.1371\/journal.pone.0223775"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/9855\/71319","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/9855\/71320","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/9855\/71319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T09:57:41Z","timestamp":1794045461000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/9855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,5]]},"references-count":103,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,8,21]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2019.241141","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,5]]}}}